Sensex reclaims 35,000 after rising over 300 points
BSE Sensex gained almost 400 points in the opening session and reclaimed the 35,000-mark. Both benchmark indices gain over 1 per cent in mooring trade.

Some of the top gainers in the stock market were Bajaj Finance, Bajaj Finserv, Cipla, Bajaj Auto, Kotak Mahindra Bank, IndusInd Bank, ICICI Bank, Axis Bank, Reliance and SBI. (Photo: Reuters)
HIGHLIGHTS
- BSE Sensex reclaimed 35,000-mark on Monday after rising over 300 points
- Shares of Cipla and Glemark Pharmaceuticals zoomed sharply
- The positive opening on Monday is also in line with global markets
Indian markets were off to a good start on Monday as both benchmarks were trading in the green, backed by banking and pharmaceutical stocks.
BSE Sensex gained almost 400 points in the opening session and reclaimed the 35,000-mark. Both benchmark indices gain over 1 per cent in mooring trade.
Some of the top gainers in the stock market were Bajaj Finance, Bajaj Finserv, Cipla, Bajaj Auto, Kotak Mahindra Bank, IndusInd Bank, ICICI Bank, Axis Bank, Reliance and SBI.
Many IT companies were among the top laggards including Wipro, Infosys, HCL Tech and TCS.
Some other stocks that descended into negative territory in early trade were ONGC, Hindalco, Mahindra and Mahindra and Ultratech Cement.
It may be noted that the shares of Mumbai-based Glenmark Pharmaceuticals surged 15 per cent to Rs 470.45 after it became the first Indian company to get approval for selling its antiviral drug Fabiflu for treatment of mild to moderate Covid-19 patients.
Shares of Cipla also surged over seven per cent after the country’s drug regulator gave it permission to manufacture and market antiviral drug remdesivir.
Today’s positive opening is also in line with global stock markets which are trying to shake off worries about a second wave of the coronavirus.
Read | World stocks turn higher despite worries over Covid-19 rebound